Exelixis, Inc. v. MSN Laboratories Private Limited et al
| Exelixis, Inc. |
| MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. |
| 1:2019cv02017 |
| October 29, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Sherry R Fallon |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 19, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
MOTION for Pro Hac Vice Appearance of Attorney Stephanie Neely - filed by Exelixis, Inc.. Motions referred to Sherry R. Fallon.(Raucci, Anthony)
|
|
SO ORDERED- re #14 MOTION for Pro Hac Vice Appearance of Attorney Stephanie Neely. Signed by Judge Sherry R. Fallon on 12/18/2019. (lih)
|
|
Pro Hac Vice Attorney Kevin J. O'Brien for Exelixis, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
|
|
Oral Order Setting Rule 16 Scheduling Conference: IT IS HEREBY ORDERED that: (1) a Scheduling Conference pursuant to Fed. R. Civ. P. 16(b) is set for 1/16/2020 at 10:00 AM in Courtroom 6C before Judge Sherry R. Fallon. (2) The parties are required to prepare for the conference by conferring on all matters under Rule 16 and D. Del. LR 16 and shall submit a proposed Scheduling Order to the Court no later than 1/13/2020. The Court's form of scheduling order is posted at http://www.ded.uscourts.gov (see Chambers, Judge Fallon, Forms). If the parties have any suggestions or modifications to the standard Scheduling Order, they may be included in the proposed order for consideration by the Court. (3) If any disputed issue exists regarding the proposed Scheduling Order, it shall be noted therein, along with the parties proposed language on the issue for consideration by the Court. Ordered by Judge Sherry R. Fallon on 12/18/2019. (lih)
|
|
SO ORDERED- re #12 PROPOSED Stipulated Protective Order. Signed by Judge Sherry R. Fallon on 12/13/2019. (lih)
|
|
Filing 13
ANSWER to #9 Answer to Complaint, Counterclaim by Exelixis, Inc..(Raucci, Anthony)
|
|
Filing 12
PROPOSED Stipulated Protective Order, by Exelixis, Inc.. (Raucci, Anthony) Modified on 12/9/2019 (nms).
|
|
Filing 11
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Pvt. Ltd. for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Stamoulis, Stamatios)
|
|
Filing 10
ORAL ORDER: The case is now referred to Magistrate Judge Sherry R. Fallon for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 11/21/2019. (nms)
|
|
CORRECTING ENTRY: The disclosure statement filed at D.I. 10 has been removed from the docket as it was filed using the incorrect code. Counsel is to refile the document using the "Disclosure Statement - Rule 7.1" filing code. (nms)
|
|
Filing 9
ANSWER to #1 Complaint, and COUNTERCLAIMS against Exelixis, Inc., by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Stamoulis, Stamatios) Modified on 11/21/2019 (nms).
|
|
Filing 8
MOTION for Pro Hac Vice Appearance of Attorney William F. Lee, Lisa J. Pirozzolo, Emily R. Whelan, Robert M. Galvin, and Kevin J. O'Brien - filed by Exelixis, Inc.. (Blumenfeld, Jack)
|
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney William F. Lee, Lisa J. Pirozzolo, Emily R. Whelan, Robert M. Galvin, and Kevin J. O'Brien, filed by Exelixis, Inc.. Signed by Judge Richard G. Andrews on 11/6/2019. (nms)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 7
AFFIDAVIT of Service for Summons, Complaint and related papers served on MSN Laboratories Private Limited on November 4, 2019, filed by Exelixis, Inc.. (Blumenfeld, Jack)
|
|
Filing 6
SUMMONS Returned Executed by Exelixis, Inc.. MSN Pharmaceuticals Inc. served on 11/1/2019, answer due 11/22/2019. (Blumenfeld, Jack)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (nmg)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2. (nmg)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/25/2019. Date of Expiration of Patent: 10/8/2030.Thirty Month Stay Deadline: 3/25/2022. (nmg)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
|
|
Filing 1
COMPLAINT for PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2765987.) - filed by Exelixis, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg)
|
|
Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Limited on 10/29/2019; MSN Pharmaceuticals Inc. on 10/29/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
